Moderna Begins First U.S. Late-Stage Vaccine Trial

The study aims to enroll 30,000 people this summer and determine whether the vaccine is safe and effective, possibly by November.
By BY DENISE GRADY from NYT Health https://ift.tt/3jH1o8O
via IFTTT
Clinical Trials, Vaccination and Immunization, Public-Private Sector Cooperation, Coronavirus (2019-nCoV), RNA (Ribonucleic Acid), Immune System, Research, your-feed-healthcare
Source New York Times
Làm đẹp Blog 247